Nanomaterials are proven to affect the biological activity of mammalian and microbial cells profoundly. Despite this fact, only surface chemistry, charge, and area are often linked to these phenomena. Moreover, most attention in this field is directed exclusively at nanomaterial cytotoxicity. At the same time, there is a large body of studies showing the influence of nanomaterials on cellular metabolism, proliferation, differentiation, reprogramming, gene transfer, and many other processes. Furthermore, it has been revealed that in all these cases, the shape of the nanomaterial plays a crucial role. In this paper, the mechanisms of nanomaterials shape control, approaches toward its synthesis, and the influence of nanomaterial shape on various biological activities of mammalian and microbial cells, such as proliferation, differentiation, and metabolism, as well as the prospects of this emerging field, are reviewed.
Atherosclerosis, being an inflammation-associated disease, represents a considerable healthcare problem. Its origin remains poorly understood, and at the same time, it is associated with extensive morbidity and mortality worldwide due to myocardial infarctions and strokes. Unfortunately, drugs are unable to effectively prevent plaque formation. Systemic administration of pharmaceuticals for the inhibition of plaque destabilization bears the risk of adverse effects. At present, nanoscience and, in particular, nanomedicine has made significant progress in both imaging and treatment of atherosclerosis. In this review, we focus on recent advances in this area, discussing subjects such as nanocarriers-based drug targeting principles, approaches towards the treatment of atherosclerosis, utilization of theranostic agents, and future prospects of nanoformulated therapeutics against atherosclerosis and inflammatory diseases. The focus is placed on articles published since 2015 with additional attention to research completed in 2019–2020.
Deoxyribozymes or DNAzymes represent artificial short DNA sequences bearing many catalytic properties. In particular, DNAzymes able to cleave RNA sequences have a huge potential in gene therapy and sequence-specific analytic detection of disease markers. This activity is provided by catalytic cores able to perform site-specific hydrolysis of the phosphodiester bond of an RNA substrate. However, the vast majority of existing DNAzyme catalytic cores have low efficacy in in vivo experiments, whereas SELEX based on in vitro screening offers long and expensive selection cycle with the average success rate of ~ 30%, moreover not allowing the direct selection of chemically modified DNAzymes, which were previously shown to demonstrate higher activity in vivo. Therefore, there is a huge need in in silico approach for exploratory analysis of RNA-cleaving DNAzyme cores to drastically ease the discovery of novel catalytic cores with superior activities. In this work, we develop a machine learning based open-source platform SequenceCraft allowing experimental scientists to perform DNAzyme exploratory analysis via quantitative observed rate constant (kobs) estimation as well as statistical and clustering data analysis. This became possible with the development of a unique curated database of > 350 RNA-cleaving catalytic cores, property-based sequence representations allowing to work with both conventional and chemically modified nucleotides, and optimized kobs predicting algorithm achieving Q2 > 0.9 on experimental data published to date. This work represents a significant advancement in DNAzyme research, providing a tool for more efficient discovery of RNA-cleaving DNAzymes. The SequenceCraft platform offers an in silico alternative to traditional experimental approaches, potentially accelerating the development of DNAzymes.
Nanomaterials of various morphologies and chemistry have an extensive use as photonic devices, advanced catalysts, sorbents for water purification, agrochemicals, platforms for drug delivery as well as imaging systems to name a few. However, search for synthesis routes giving custom nanomaterials for particular needs with the desired structure, shape, and size remains a challenge and is often implemented by manual research articles screening. Here, we develop for the first time scanning and transmission electron microscopy (SEM/TEM) reverse image search and hand drawing-based search via transfer learning (TL), namely, VGG16 convolutional neural network (CNN) repurposing for image features extraction and subsequent image similarity determination. Moreover, we demonstrate case use of this platform on calcium carbonate system, where sufficient amount of data was acquired by random high throughput multiparametric synthesis, as well as on Au nanoparticles (NPs) data extracted from the articles. This approach can be not only used for advanced nanomaterials search and synthesis procedure verification, but also can be further combined with machine learning (ML) solutions to provide data-driven novel nanomaterials discovery.
Six small interference RNAs (siRNAs) have been approved as therapeutics making them promising nanosystems due to selective gene knockdown activity. siRNA design is complex due to various factors, where the chemical modifications are crucial to improve its half-life and stability. Machine learning (ML) enabled more efficient analysis of siRNA data, moreover predicting efficacy and off-target effects. This work proposes a novel pipeline for predicting gene knockdown activity of chemically modified siRNAs across the whole range of activities leveraging both descriptors of siRNA chemical composition-aware property matrices and large language model (LLM) embeddings for target gene encoding. Several general-purpose and domain-specific fine tuned LLMs were benchmarked on the target task, where the Mistral 7B general-purpose model outperformed even the models pre-trained on genomic data. Proposed model based on meta-learning mechanism successfully mitigates data imbalance towards moderate-to-high active constructs and achieves state-of-the-art (SOTA) quality with R2 = 0.84 and a RMSE = 12.27% on unseen data, where the probabilistic outputs of classifiers trained with F-scores up to 0.92 were used as additional descriptors. By filling the gap in the field of advanced chemical composition-aware siRNA design, our model aims to improve the efficacy of developed siRNA-based therapies.